Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Temporal arteritis epidemiology and demographics

Introduction

Overview

Overview

Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older. The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years. Temporal arteritis commonly affects individuals older than 70 years of age. Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis. Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1. The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older.[1]

Age

  • The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years.[2]
  • Temporal arteritis commonly affects individuals older than 70 years of age.[3][4]

Race

  • Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis.[5][6]

Gender

  • Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1.[5]

Region

Developed Countries

  • The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.[7]
References

References

  1. ↑ Goodwin JS (1992). “Progress in gerontology: polymyalgia rheumatica and temporal arteritis”. J Am Geriatr Soc. 40 (5): 515–25. PMIDΒ 1634709.
  2. ↑ Kermani TA, SchΓ€fer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL; et al. (2010). “Increase in age at onset of giant cell arteritis: a population-based study”. Ann Rheum Dis. 69 (4): 780–1. doi:10.1136/ard.2009.111005. PMIDΒ 19854712.
  3. ↑ Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2004). “Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period”. Arthritis Rheum. 51 (2): 264–8. doi:10.1002/art.20227. PMIDΒ 15077270.
  4. ↑ Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A; et al. (2007). “Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study”. Medicine (Baltimore). 86 (2): 61–8. doi:10.1097/md.0b013e31803d1764. PMIDΒ 17435586.
  5. ↑ 5.0 5.1 Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J; et al. (2009). “Epidemiology of giant cell arteritis and polymyalgia rheumatica”. Arthritis Rheum. 61 (10): 1454–61. doi:10.1002/art.24459. PMIDΒ 19790127.
  6. ↑ Artal NM, Rodriguez M, Luna JD, Reviglio VE, Cuello O, MuiΓ± JC; et al. (2002). “Giant cell arteritis in a Hispanic population”. Ophthalmology. 109 (10): 1757, discussion 1757. PMIDΒ 12359586.
  7. ↑ Smeeth, L (2006). “Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001”. Annals of the Rheumatic Diseases. 65 (8): 1093–1098. doi:10.1136/ard.2005.046912. ISSNΒ 0003-4967.

Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]